Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.970
+0.040 (2.07%)
At close: Dec 20, 2024, 4:00 PM
1.960
-0.010 (-0.51%)
After-hours: Dec 20, 2024, 7:43 PM EST
PACB Revenue
Pacific Biosciences of California had revenue of $39.97M in the quarter ending September 30, 2024, a decrease of -28.23%. This brings the company's revenue in the last twelve months to $173.15M, up 2.14% year-over-year. In the year 2023, Pacific Biosciences of California had annual revenue of $200.52M with 56.29% growth.
Revenue (ttm)
$173.15M
Revenue Growth
+2.14%
P/S Ratio
3.08
Revenue / Employee
$217,521
Employees
796
Market Cap
539.51M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 200.52M | 72.22M | 56.29% |
Dec 31, 2022 | 128.30M | -2.21M | -1.69% |
Dec 31, 2021 | 130.51M | 51.62M | 65.43% |
Dec 31, 2020 | 78.89M | -12.00M | -13.20% |
Dec 31, 2019 | 90.89M | 12.27M | 15.60% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
InnovAge Holding | 786.51M |
Talkspace | 181.29M |
Semler Scientific | 58.94M |
Phathom Pharmaceuticals | 26.27M |
CorMedix | 12.26M |
Opthea | 261.86K |
PACB News
- 16 days ago - Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight - Benzinga
- 5 weeks ago - Pacific Biosciences' Cost Cuts Won't Offset Rising Competition - Seeking Alpha
- 6 weeks ago - PacBio to Present at Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Pacific Biosciences of California, Inc. (PACB) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028 - GlobeNewsWire
- 6 weeks ago - PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop - GlobeNewsWire
- 6 weeks ago - The Schall Law Firm Encourages Investors With Losses To Join An Inquiry Into Pacific Biosciences of California Inc For Fraud - Accesswire
- 6 weeks ago - Pacific Biosciences of California, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm - Accesswire